The rapidly expanding spectrum of TSC/MTOR mutation-associated renal tumors may pose diagnostic challenges for general pathologists given the rarity of some of the entities, the overlap in morphologic features, and the limited availability of some IHC stains. This evidence concerns the gene MTOR and kidney neoplasm.